COVID-19 Could Trigger Recurrent Guillain-Barre Syndrome

Guillain-Barre Syndrome (GBS) a rare disorder where the body’s immune system attacks the nerves. As the condition worsens it could quickly spread, eventually paralyzing the whole body. Recent research has revealed that COVID-19 could cause a wide range of immune neuropathies, including GBS. COVID-19 has also been linked to the worsening of chronic inflammatory demyelinating polyradiculopathy.

The study highlights a 43-year-old man who was in a motor accident. He had suffered lumbosacral and cervical spine injuries and was diagnosed with a herniated disc. Four years later, he had developed acute illness with fever, cough, and ageusia. He was diagnosed with influenza A. Three days after the first diagnosis he developed numbness in both legs and arms. He had facial weakness and slurred speech. He recovered without any treatment. He had two similar episodes.

In April 2020 (now 54-year-old), he presented with complaints of progressive difficulty in swallowing. He had a fever for three days followed by weakness in the legs, arms, and face. An RT=PCR test for COVID-19 was positive. He was treated for GBS secondary to COVID-19. The researchers recommend close observation for neurologic symptoms for patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19.

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit

Want to set up an online consultation for your practice, Click here

Ref link: